Get started
RAIL Long Trade Setup! 🔥 📈 Breakout Potential: RAIL is breaking out from a consolidation triangle, signaling bullish momentum. 📊 Key Levels: Entry: $12.72 ✅ Stop Loss (SL): $12.00 🛡️ Target 1 (T1): $13.35 🎯 Target 2 (T2): $14.05 🚀 🔍 Volume Confirmation: Look for increasing buying pressure to confirm the breakout. 💡 Opportunity: A promising setup with favorable risk-reward and strong upside potential. 💥 #RAIL #StockTrading #TradingView #LongTrade #BullishSetup #StockMarket #TechnicalAnalysis #ChartPatterns #MomentumTrading #SwingTrading #RiskManagement #ProfitableTrading #BreakoutAnalysis
NASDAQ:RAILLong
by ProfittoPath
3
Nvidia. Analysis and Price Forecast: A Strategic OutlookIntroduction: Nvidia Inc. (NASDAQ: NVDA) continues to be at the forefront of the AI and semiconductor revolution, showcasing robust innovation and a compelling business model. This analysis leverages advanced tools such as TheWaved™ and utilizes VSA Analysis, Technical Indicators, Price Action, and Fundamental Analysis to craft a comprehensive forecast. Recent Price Movements and Key Patterns: 1. Candle Pattern Analysis: From the provided patterns sequence data: January 13, 2025, 14:00: Pattern: "Increased Buy Volumes" Movement: +6.69% from open to close, suggesting strong buyer activity and market confidence. January 10, 2025, 16:00: Pattern: "Buy Volumes Take Over" Movement: -5.7%, indicating potential sell-offs after profit-taking. These patterns highlight the recent tug-of-war between buyers and sellers, creating opportunities for strategic entries and exits. 2. Key Levels and Trend Analysis: From technicals: Current Price: $135.19 Resistance Levels: Short-Term: $139.48 (MA200 on the hourly chart) Mid-Term: $141.15 (MA100) Support Levels: Immediate: $127.30 Key Support Zone: $123.69-$127.30 Nvidia's price is trading below critical moving averages (e.g., MA50 and MA200), suggesting a potential rebound or consolidation phase before further directional movement. Multi-Dimensional Analysis: 1. Volume Spread Analysis (VSA): Analysis: Strong buy patterns are evident, with significant volume upticks near critical support zones. This implies institutional interest in accumulation phases. Prediction: Anticipate continuation of buying pressure if price stabilizes above $135. Resistance at $140 may pose challenges in the short term. 2. Fundamental Insights: Nvidia’s Q4 earnings report showed record revenue driven by AI GPU demand. Major customers in cloud computing and automotive industries continue to bolster growth. However, rising interest rates and potential geopolitical risks (e.g., China’s tech policies) might pressure valuations. 3. Price Action Analysis: Recent bullish engulfing candles near $127 indicate buyer confidence. Price may revisit $130 before testing $140. Breaking $140 could pave the way to retest $150 (January’s absolute high). Projections: Short-Term (1 Week): Target: $138.50 Stop-Loss: $132.00 Rationale: A breakout above MA50 ($136.93) will signal short-term bullish momentum. Mid-Term (1 Month): Target: $145.00 Stop-Loss: $130.00 Rationale: Stabilization above $140 supported by institutional buying and potential macroeconomic support. Long-Term (3-6 Months): Target: $160.00 Stop-Loss: $125.00 Rationale: Continued demand for Nvidia’s GPUs in AI and automotive applications combined with broader tech sector recovery. Strategic Recommendations: Support Levels: - 1. 127.3 2. 123.69 3. 113.9 4. 90.4855 5. 87.88 Resistance Levels: - 1. 127.3 2. 123.69 3. 113.9 4. 90.4855 5. 87.88 Powerful Support Levels: - Powerful Resistance Levels: - 1. 89.599 2. 89.599 3. 63.974 4. 63.974 5. 48.462 Above $160: Consider reducing positions to hedge against potential market corrections. 3. Stop-Loss & Risk Management: Strict stop-loss at $130 for short-term trades. Trail stops to lock profits as price moves favorably. Tools and Insights: Analysis powered by TheWaved™, leveraging decades of professional experience and cutting-edge analytics. Key insights have been shared to align with both retail and institutional perspectives. Call to Action: For personalized queries or deeper insights into Nvidia’s price action, feel free to reach out via direct message. Explore our tools and indicators through the link in our profile. Concept of Rays Explanation of the "Rays from the Beginning of Movement" Concept Core Idea My proprietary analysis method is based on using rays constructed on Fibonacci mathematical and geometric principles. These rays create a system of dynamic levels that help predict precise asset movements and identify key zones where price interactions occur. Price interaction with these rays signals probable scenarios: either a reversal or a continuation of movement, but only after interaction and the appearance of dynamic factors and patterns. Why Predicting Specific Levels is Not Possible Financial markets are nonlinear systems, where price movement is determined by numerous variables, including market volumes, liquidity, macroeconomic factors, and participant psychology. Instead of attempting to predict specific levels, I propose analyzing probabilities of price reaction at pre-calculated key zones. Price interaction with rays provides additional insights into the direction and strength of movement. Disclaimer: This analysis reflects the author’s perspective based on available data and does not constitute financial advice. Trading involves risks; ensure proper due diligence. Follow TheWaved for more actionable insights!
NASDAQ:NVDALong
by brandlabelden
1
Oracle Stock (ORCL) Surges Amid Trump’s InitiativeOracle Stock (ORCL) Surges Amid Trump’s Initiative Stargate – an initiative unveiled by Donald Trump on his second day as president – represents a collaborative project between OpenAI, SoftBank, and Oracle to advance artificial intelligence infrastructure in the United States. The project’s partners also include Microsoft, MGX, Arm, and NVIDIA. The initiative involves an initial $100 billion investment to construct a data centre in Texas, with total funding potentially increasing to $500 billion over four years. Additionally, President Trump has revoked an executive order from his predecessor, Joe Biden, issued in 2023, which aimed to mitigate risks associated with AI development. Financial markets responded with a rally in tech stocks, with Oracle’s stock (ORCL) gaining over 7% in a single day. Technical analysis of the ORCL chart shows: → Price fluctuations are forming an ascending channel, and yesterday’s rally lifted the price from the lower half of the channel to its median line. → The price is approaching a bearish gap created on December 10 following disappointing quarterly results. This gap may act as resistance – similar to the inverse situation earlier in 2025, where the price found support at the upper boundary of a bullish gap formed after the September earnings report. However, with support from the new administration, bulls might manage to sustain levels above $180, paving the way for a potential climb to a new all-time high around the psychological mark of $200 per ORCL share. According to TipRanks: → 15 out of 27 analysts recommend buying ORCL stock. → The average 12-month price target for ORCL is $197. Trade on TradingView with FXOpen. Consider opening an account and access over 700 markets with tight spreads from 0.0 pips and low commissions from $1.50 per lot. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NYSE:ORCL
by FXOpen
1
TFC Truist Financial Corporation Options Ahead of Earnings If you haven`t sold TFC before the regional banks selloff: Now analyzing the options chain and the chart patterns of TFC Truist Financial Corporation prior to the earnings report this week, I would consider purchasing the 40usd strike price Calls with an expiration date of 2025-1-17, for a premium of approximately $3.85. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
NYSE:TFCLong
by TopgOptions
Starbucks Corporation: Elliott Wave Correction UnfoldingNASDAQ:SBUX Overview: Starbucks is in the midst of an Elliott Wave corrective structure, likely entering the C-wave of an ABC correction. The bearish momentum suggests that the correction isn't complete, presenting an opportunity to short as the structure completes. Elliott Wave Analysis: Wave A: The initial impulsive wave down broke key support levels, signaling the start of a correction. This wave exhibited strong bearish momentum. Wave B: The corrective upward retracement faced resistance near $93.12, forming a potential lower high and respecting the descending channel. With failure to break out above $94, this wave has likely concluded, paving the way for the final corrective wave. Wave C: Currently forming, this wave is expected to extend toward lower Fibonacci retracement levels, targeting $88.71, $84.29, and $79.88. The typical symmetry in Elliott Wave corrections suggests that Wave C may equal or exceed the length of Wave A. Key Trading Levels: Entry: $93.12 (near the end of Wave B). Stop Loss: $94.00 (just above Wave B resistance). Target 1: $88.71 (38.2% Fibonacci extension of Wave A). Target 2: $84.29 (61.8% extension and channel support). Target 3: $79.88 (full measured move of Wave C and strong support). Trading Strategy: Short Entry: Look for confirmation of rejection near $93.12. This aligns with the conclusion of Wave B and the start of Wave C. Risk Management: Place a tight stop-loss at $94, above the resistance line formed by Wave B. Profit-Taking: Scale out of positions as price approaches each Fibonacci target and key support zones. Additional Notes: The Elliott Wave correction is part of a broader descending wedge structure. A decisive breakdown could trigger a stronger bearish continuation. Confluence of technical factors (Fibonacci levels, trendline resistance, and Elliott Wave symmetry) supports the bearish scenario. Monitor volume and RSI for divergences to confirm the wave progression. Disclaimer: This analysis is for informational and educational purposes only and should not be considered as financial advice. Trading and investing involve significant risks, and you should consult with a qualified financial advisor or conduct your own research before making any investment decisions. The author is not responsible for any financial losses or decisions made based on this analysis. Always trade responsibly and within your own risk tolerance.
NASDAQ:SBUXShort
by Whisperwave
Netflix on the Rise Bullish Breakout in Motion!Trendline Support The price is respecting an ascending trendline, indicating a strong bullish sentiment. Recent candles have bounced off this support line, confirming its reliability. Breakout Confirmation The price has broken above a key horizontal resistance level around $870. This breakout suggests bullish continuation, especially with volume support. Risk-to-Reward Setup A well-defined risk-to-reward ratio is visible. Stop-loss appears to be placed below $853, protecting against a false breakout. Target set around $939 aligns with a significant resistance zone, offering a potential reward. Indicators Positive price momentum is evident, with higher highs and higher lows forming. Likely supported by broader market strength in tech stocks. Next Steps Monitor the price action for sustained movement above $870. A retracement to retest the breakout level could provide a secondary entry. Key resistance to watch: $900 and $939. NFLX is poised for a bullish continuation, with the current setup offering a high-probability trade opportunity.
NASDAQ:NFLXLong
by wolfchemist
1
APD - a stalwart trending up -- LONG @ 321.97APD (not to be confused with ADP) is in the midst of a pullback in a strong uptrend. The white lines mark 6 month highs and lows, and the 6 month Trend Strength Indicator is at .88 (0-1 scale) and has been in that vicinity since August. It's also a top 20 (top 3%) big cap composite score stock for me, reflecting a robust backtest history (almost 1900 trades going back to 1968), solid outperformance (.11%/day held), quick turnaround on trades (13 days avg - that's really solid for a stock with that many trades that cover whole market meltdown periods), and low trading system max drawdown (worst is < 9% since 1968). It can get streaky and go down for a couple of weeks at a time and has done so twice in the last 6 months, so it's definitely an average in type of trade. Full disclosure, this is a hypothetical trade for me - my portfolio is full of petulant stocks that don't want to go up right now so I'm capped. But a daily return on almost 1900 trades going back over 50 years that's almost 3x the S&P's long term daily average is worth sharing. In theory, per my usual strategy, l add at the close on any day it is still oversold and I will use FPC (first profitable close) to exit any lot on the day it closes at any profit. As always - this is intended as "edutainment" and my perspective on what I am or would be doing, not a recommendation for you to buy or sell. Act accordingly and invest at your own risk. DYOR and only make investments that make good financial sense for you in your current situation. P.S. The chart should look better than that but for some reason, what it looks like when I hit publish and what shows up after I do haven't always been the same lately, for some reason.
NYSE:APDLong
by redwingcoach
11
Tempus AI: Analyzing Tempus AI, Inc. (NASDAQ: TEM): Is It a Buy Industry Position and Growth Potential · Market Trends: The AI in healthcare market is projected to grow at a compound annual growth rate (CAGR) of approximately 45.1% from 2023 to 2030, driven by demand for personalized medicine and advancements in AI technology. · Competitive Landscape: Tempus AI competes with companies like IBM Watson Health and Google Health. However, Tempus's data-driven approach and partnerships with academic and research institutions provide differentiation. Financial Performance · Revenue Growth: Tempus AI has shown revenue growth, with a projected increase of 30% year-over-year for Q4 2024. The company's revenue for FY2024 is expected to reach $705.74 million. · Profitability Metrics: · Gross Margin: Improving gross margins indicate better cost management and operational efficiency. · Operating Margin: The company is progressing towards profitability, as suggested by narrowing operating losses. · Net Income: Recent trends towards profitability signal positive long-term prospects. · Balance Sheet Health: · Debt-to-Equity Ratio: Maintaining a low debt-to-equity ratio supports financial stability. Tempus AI manages its debt levels prudently. · Cash Reserves: Adequate cash reserves enable investment in R&D and help navigate market uncertainties. Innovation and Research · R&D Investments: Substantial investment in R&D reflects Tempus AI's commitment to innovation. Ongoing development of algorithms and technologies positions the company well in the AI healthcare market. · Intellectual Property: Patents and proprietary technologies protect Tempus AI's innovations and provide a competitive edge. Management and Governance · Leadership Team: A management team with experience in healthcare and technology is crucial. Tempus AI's leadership has a track record in driving growth and innovation. · Corporate Governance: Transparent practices and policies that prioritize shareholder interests enhance investor confidence. Market Sentiment and Analyst Opinions · Analyst Ratings: Analysts generally give a "Buy" rating, reflecting positive expectations for Tempus AI's future performance. The average price target of $57.20 suggests a potential upside of 20.07%. · Investor Confidence: Institutional investments and insider buying can indicate confidence in the company's prospects. Is Tempus AI a Buy or Sell? Based on the expanded analysis: Pros: · High-growth industry with substantial market potential. · Technological capabilities and strong data assets. · Positive revenue growth and progress towards profitability. · Strategic partnerships and collaborations enhance market position. Cons: · Competition from other AI healthcare technology firms. · Regulatory challenges specific to the healthcare sector. · Financial risks if profitability is not achieved as expected. Rating: For investors with a higher risk tolerance and a long-term investment horizon, Tempus AI could be considered a "Buy". Personal due diligence is essential, along with consideration of individual financial goals. Strategy - Utilizing Call Options Buying call options can leverage Tempus AI's potential stock appreciation. Benefits of Call Options: · Leverage: Options allow control of more shares with less capital compared to directly purchasing stock. · Risk Management: The maximum loss is limited to the premium paid for the option, providing defined risk. · Flexibility: Options with 1 to 12-month expiries align with specific company milestones or market events. Example Strategy: · 1-Month Expiry Call: Suited for short-term strategies, such as upcoming earnings reports or product launches. · 6-Month to 12-Month Expiry Call: Ideal for longer-term strategies, allowing benefit from anticipated growth or industry developments. Risks and Considerations · Time Decay (Theta): Options lose value as expiration approaches, particularly if the stock price does not move favorably. · Volatility (Vega): High volatility can increase option premiums but also introduces higher risk. · Market Risk: Unpredictable market conditions can affect stock prices regardless of the company's performance. · Liquidity Risk: Options with low trading volume may be harder to sell at a desired price. Risk Management · Diversification: Avoid allocating all investment capital to a single company or strategy. · Position Sizing: Only risk a small percentage of your portfolio on options trades. · Stay Informed: Keep up with news about Tempus AI, industry trends, and market conditions. · Set Clear Goals: Define entry and exit points. Consider using stop-loss orders to manage potential losses. Trading Is Risky Trading, especially with derivatives like options, involves significant risk and may not be suitable for everyone. Potential for high returns comes with the possibility of substantial losses. · Understand Before You Invest: Ensure full understanding of how options work and the risks involved. · Seek Professional Advice: Consult with a financial advisor for personalized guidance based on your financial situation and investment goals. Conclusion Tempus AI, Inc. presents an opportunity in the evolving AI healthcare sector. The company's innovative approach, revenue growth, and strategic partnerships make it a compelling investment prospect. It's crucial to weigh risks and consider personal risk tolerance before making decisions. Risk Warning Trading stocks and options is a risky activity and can result in losses. You should only trade if you understand the risks involved and are comfortable with the potential for losses. Rating: Buy Risk Disclaimer! The article and the data is for general information use only, not advice! Risk Disclaimer! General Risk Warning: Trading on the Financial Markets, Stock Exchange and all its asset derivatives is highly speculative and may not be suitable for all investors. Only invest with money you can afford to lose and ensure that you fully understand the risks involved. It is important that you understand how Trading and Investing on the stock exchange works and that you consider whether you can afford the high risk of loss.
NASDAQ:TEMLong
by TheTrade_Academ
ARM Explodes Higher! Is There More Upside Ahead? Jan. 23Technical Analysis (TA) for Trading: 1. Trend Analysis: * ARM has recently broken out of a consolidation phase and is in a strong uptrend on the hourly chart. * The price surged past resistance at $150 and is currently testing the $180 level. * A rising wedge pattern suggests possible consolidation or a pullback. 2. Key Levels: * Resistance: $182.88 (recent high), $185 (psychological resistance). * Support: $175 (key intraday support), $160 (previous breakout level). 3. Indicators: * MACD: Bullish momentum but showing signs of weakening. Watch for a potential crossover for reversal signals. * Stochastic RSI: Overbought, signaling potential short-term profit-taking or consolidation. 4. Volume: * Strong breakout volume indicates bullish interest, but declining volume near $180 suggests weakening momentum. 5. Outlook: * Bullish above $175 with potential retests of $185 or higher. * Bearish if $175 breaks; watch for a pullback toward $160. GEX Analysis for Options Trading: 1. Gamma Exposure (GEX): * Highest Positive NETGEX: $160, acting as strong support. * CALL Walls: $175 (68.93% GEX7) and $180 (78.79% GEX8), significant resistance zones. 2. Options Flow: * IVR: 24.8, indicating low implied volatility relative to the past year. * IVx Avg: 81, slightly elevated, suggesting a moderately bullish sentiment. * CALL Activity: 73.2%, heavily skewed toward bullish positioning. 3. Trading Strategy: * Bullish Setup: * Buy Calls: $180 Strike (expiring 1-2 weeks). * Entry: Near $175 support. * Target: $185-$190. * Stop-Loss: Below $170. * Bearish Setup: * Buy Puts: $170 Strike (expiring 1-2 weeks). * Entry: Near $182 resistance. * Target: $160. * Stop-Loss: Above $185. Actionable Suggestions: * Monitor $175 for bullish continuation or breakdown signals. * If momentum weakens, consider short-term profit-taking or protective puts. * Options traders should focus on strikes aligned with GEX levels ($175 CALLs or $170 PUTs). Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Always do your own research and manage risk effectively.
NASDAQ:ARM
by BullBearInsights
$ELV Earnings Preview: Oversold Potential + Key Metrics AheadEarnings Estimates: Analysts forecast an EPS of $3.82 for the upcoming quarter, indicating a 32% year-over-year decline. Revenue is projected at $44.67 billion, a 5.2% increase from the same period last year. Oversold Potential: With an oversold score of 59%, NYSE:ELV appears attractive for accumulation. PEG Ratio: The PEG ratio stands at -0.77, suggesting undervaluation despite negative growth. Valuation Metrics: A forward P/E of 11.03, lower than the trailing P/E of 14.14, indicates potential undervaluation. Revenue Growth: Positive quarterly revenue growth estimates point to resilient performance. In the previous quarter, Elevance reported an EPS of $8.37, missing the consensus estimate of $9.66, but achieved a 5.3% year-over-year revenue increase to $44.72 billion. Guidance: In the previous quarter, Elevance Health revised its full-year 2024 adjusted EPS guidance downward to approximately $33, down from the prior estimate of $37.20, due to challenges in its Medicaid business. Despite these hurdles, Elevance's diversified portfolio and strategic initiatives position it for potential growth.
NYSE:ELV
by Solidified
CVS Health Corp | CVS | Long at $43Not much to write about here except the stock has reentered the "crash" simple moving average area (see green lines). Often, this signals an overall bottom, but it doesn't mean a further dip below $40 isn't possible in the near-term. Personally, I can't ignore this reentry and thus have started a position at $43 (after closing out a previous position in October in the $60's). The company has a lot of headwinds, but if Walgreens NASDAQ:WBA is also in trouble, is NYSE:CVS too big to fail in the short-term? Target #1 = $53.00 Target #2 = $60.00 Target #3 = $65.00 Target #4 = $68.00
NYSE:CVSLong
by WorthlessViews
Teladoc Health | TDOC | Long at $9.91Teladoc Health NYSE:TDOC - Initial position started at $9.91 with the potential for the price gap in the $7's to be closed in the near future (likely another entry there unless fundamentals change) Pros: User base of over 90 million and growing Revenue grew from $555 million in 2019 to $2.6 billion through Q3 of 2024 Positive free cash flow since 2021 Low debt (debt to equity ratio around 1x) AI integration and partnership with Amazon and Brightline Historical simply moving average is approaching price, which often leads to a jump or change in downward momentum in the longer-term Cons: Currently unprofitable and not forecast to become profitable over the next 3 years Lots of insider selling and exercising of options No dividend Daily price gap in the $7 dollar range which may close prior to move up Targets through 2027 : $14.20 $20.00 $27.00 $35.00 $55.00 (long-term, positive outlook)
NYSE:TDOCLong
by WorthlessViews
1
AMD Harmonic Elliott Wave and Hurst Cyclic AnalysisLet’s revisit the key points from my last update on AMD, published on November 27th: We are currently correcting the bullish move from October 2022 to March 2024. Wave A of the second zigzag (labeled 'y') is nearing completion. The October 2023 trough aligns with an 80-week (80W) cycle trough. The first 20-week (20W) cycle within this 40W cycle was anticipated around December 18th. A rally is expected to follow before entering the extreme bearish phase. The 80W cycle trough is projected for early April 2025. Although the 20W cycle trough took slightly longer to form than expected, the overall analysis remains intact. We are currently progressing through wave B of y of (II), which I believe could push prices as high as 144. The 80W cycle trough is now projected for early May 2025.
NASDAQ:AMD
by bamdadsalarieh